Serum bilirubin levels in familial hypercholesterolemia: A new risk marker for cardiovascular disease?

Journal of Lipid Research

Volumn 52, Issue 9, 2011, Pages 1755-1759

  De Sauvage Nolting, Pernette R W ^a   Kusters, D Meeike ^b   Hutten, Barbara A ^b   Kastelein, John J P ^b  

^a Cardiology Centers of The Netherlands   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Drug therapy; Oxidized lipids; Statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG TARGETING; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEART PROTECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; BILIRUBIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; RISK FACTORS; SIMVASTATIN; YOUNG ADULT;

EID: 80051806943     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P013193     Document Type: Article

References (33)

1. Schwertner, H A, and L. Vitek. 2008. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 198: 1-11.
2. Hopkins, P N, L L Wu, S C Hunt, B C James, G M Vincent, and R R Williams. 1996. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16: 250-255. (Pubitemid 26056243)
3. Levinson, S S 1997. Relationship between bilirubin, apolipoprotein B, and coronary artery disease. Ann. Clin. Lab. Sci. 27: 185-192. (Pubitemid 27194609)
4. Schwertner, H A, W G Jackson, and G. Tolan. 1994. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem. 40: 18-23. (Pubitemid 24050206)
5. Breimer, L H, G. Wannamethee, S. Ebrahim, and A G Shaper. 1995. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin. Chem. 41: 1504-1508.
6. Djousse, L., D. Levy, L A Cupples, J C Evans, R B D'Agostino, and R C Ellison. 2001. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am. J. Cardiol. 87: 1196-1200. (Pubitemid 32453243)
7. Troughton, J A, J V Woodside, I S Young, D. Arveiler, P. Amouyel, J. Ferrieres, P. Ducimetiere, C C Patterson, F. Kee, J W Yarnell, et al. 2007. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur. J. Cardiovasc. Prev. Rehabil. 14: 79-84.
8. Temme, E H, J. Zhang, E G Schouten, and H. Kesteloot. 2001. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 12: 887-894. (Pubitemid 34048869)
9. Hunt, S C, L L Wu, P N Hopkins, and R R Williams. 1996. Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees. Arterioscler. Thromb. Vasc. Biol. 16: 912-917. (Pubitemid 26266887)
10. Novotny, L, and L. Vitek. 2003. Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies. Exp. Biol. Med. (Maywood). 228: 568-571. (Pubitemid 37203679)
11. Stocker, R., Y. Yamamoto, A F McDonagh, A N Glazer, and B N Ames. 1987. Bilirubin is an antioxidant of possible physiological importance. Science. 235: 1043-1046. (Pubitemid 17049750)
12. Stocker, R., A N Glazer, and B N Ames. 1987. Antioxidant Activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA. 84: 5918-5922. (Pubitemid 17130420)
13. Wu, T W, K P Fung, and C C Yang. 1994. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci. 54: 477-481.
14. Nakagami, T., K. Toyomura, T. Kinoshita, and S. Morisawa. 1993. A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta. 1158: 189-193. (Pubitemid 23291461)
15. Lansberg, P J, S. Tuzgol, M A Van de Ree, J C Defesche, and J J Kastelein. 2000. [Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands] Ned. Tijdschr. Geneeskd. 144: 1437-1440.
16. Brown, M S, and J L Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47. (Pubitemid 16037973)
17. De Sauvage Nolting, P R, R J Buirma, B A Hutten, and J J Kastelein. 2002. Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia [the Examination of Probands and Relatives in Statin Studies with Familial Hypercholesterolemia (ExPRESS FH)]. Am. J. Cardiol. 90: 181-184.
18. Defesche, J C 2000. Familial hypercholesterolaemia. In Lipids and Vascular Disease. D. J. Betteridge, editor. Dunitz, London. 65-76.
19. Friedewald W T, R I Levy, D S Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
20. Perry, B W, B T Doumas, D D Bayse, T. Butler, A. Cohen, W. Fellows, C C Garber, B. Howell, T. Koch, S. Krishnamurthy, et al. 1983. A candidate reference method for determination of bilirubin in serum. Test for transferability. Clin. Chem. 29: 297-301. (Pubitemid 13138291)
21. Vitek, L., L. Novotny, M. Sperl, R. Holaj, and J. Spacil. 2006. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc. Dis. 21: 408-414. (Pubitemid 44617309)
22. Erdogan, D., H. Gullu, E. Yildirim, D. Tok, I. Kirbas, O. Ciftci, S T Baycan, and H. Muderrisoglu. 2006. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 184: 431-437. (Pubitemid 43049731)
23. Wu, T W, K P Fung, J. Wu, C C Yang, and R D Weisel. 1996. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem. Pharmacol. 51: 859-862. (Pubitemid 26096296)
24. Neuzil, J, and R. Stocker. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269: 16712-16719.
25. Grosser, N., A. Abate, S. Oberle, H J Vreman, P A Dennery, J C Becker, T. Pohle, D S Seidman, and H. Schroder. 2003. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem. Biophys. Res. Commun. 308: 956-960.
26. Ebong, P E, E U Eyong, and E O Udosen. 1998. Effects of aspirin (acetylsalicylic acid) and Cataflam (potassium diclofenac) on some biochemical parameters in rats. Afr. J. Med. Med. Sci. 27: 243-246.
27. Schwertner, H A 1998. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis. 136: 383-387. (Pubitemid 28133428)
28. Miyake, K., N. Miyake, S. Kondo, Y. Tabe, A. Ohsaka, and T. Miida. 2009. Seasonal variation in liver function tests: A time-series analysis of outpatient data. Ann. Clin. Biochem. 46: 377-384.
29. Grosser, N., K. Erdmann, A. Hemmerle, G. Berndt, U. Hinkelmann, G. Smith, and H. Schroder. 2004. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem. Biophys. Res. Commun. 325: 871-876. (Pubitemid 39487953)
30. Grosser, N., A. Hemmerle, G. Berndt, K. Erdmann, U. Hinkelmann, S. Schurger, N. Wijayanti, S. Immenschuh, and H. Schroder. 2004. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic. Biol. Med. 37: 2064-2071. (Pubitemid 39491325)
31. Hsu, M., L. Muchova, I. Morioka, R J Wong, H. Schroder, and D K Stevenson. 2006. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem. Biophys. Res. Commun. 343: 738-744.
32. Lee, T S, C C Chang, Y. Zhu, and J Y Shyy. 2004. Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection. Circulation. 110: 1296-1302. (Pubitemid 39202348)
33. Hunt, S C, F. Kronenberg, J H Eckfeldt, P N Hopkins, R H Myers, and G. Heiss. 2001. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: The NHLBI family heart study. Atherosclerosis. 154: 747-754. (Pubitemid 32232174)